VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Hims & Hers Health, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Hims & Hers Health, Inc.
HIMS · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Hims & Hers Health, Inc.'s moat claims, evidence, and risks.
View HIMS analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 51 / 100 for Hims & Hers Health, Inc.).
- Segment focus: Hims & Hers Health, Inc. has 2 segments (97.4% in Online Platform); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Hims & Hers Health, Inc. has 3 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
Hims & Hers Health, Inc.
Online Platform
Direct-to-consumer telehealth + subscription pharmacy (cash-pay) for lifestyle and chronic conditions
Primarily United States
Consumers (end-users), paid out-of-pocket; supported by affiliated provider networks and pharmacy fulfillment
D2C digital health platform + fulfillment (mail-order pharmacy and partners)
97.4%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Hims & Hers Health, Inc. strengths
Sanofi strengths
Segment mix
Hims & Hers Health, Inc. segments
Full profile >Online Platform
Competitive
Wholesale
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.